INDICATIONS: hypertention. ACTIONS: competitively blocks alpha- an beta- receptor sites in the SNS leading to LOWER BLOOD PRESSURE. PHARMACOKINETICS: given by PO or IV. ADVERSE EFFECTS: Dizziness, vertigo, fatigue, gastric pain, flatulence, bronchospasm, dypnea, cough, and decrease exercise tolerance. ASSESSMENT should include allergies, bradycaria, heart blocks, shock, CHF, asthma, or DM. BASELINE should include skin colour, temperature, pulse, BP, cardiac output, ECG, respiration, aventitious sounds, and blood glucose levels and electrolytes (p. 493).